Skip to main content
Inpatient Procedure Code

3E0J7U1 ICD-10-PCS Code: Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

Introduce Nonaut Pancr Islet in Bil/Panc Tract, Via Opening

Axis Breakdown

Every ICD-10-PCS code is exactly seven characters, one per axis. Each character's meaning is defined by its position in the code.

PositionValueMeaning
1
Section3

Administration

2
Body SystemE

Physiological Systems and Anatomical Regions

3
Root Operation0

Introduction

Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products

4
Body System / RegionJ

Biliary and Pancreatic Tract

5
Approach7

Via Natural or Artificial Opening

6
SubstanceU

Pancreatic Islet Cells

7
Qualifier1

Nonautologous

MS-DRG Grouper Relationships (FY2026)

Potential MS-DRG participation — not a DRG assignment.

The MS-DRG grouper treats this as a non-operating-room procedure. It appears in the surgical logic of 3 MS-DRGs:

From the CMS MS-DRG Definitions Manual, Appendix E. Actual DRG assignment depends on the complete claim.

Related Codes

Same operation — other Approach

Same table and root operation, differing only in the approach character.

3E0J3U1 — Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Percutaneous Approach, 3E0J8U1 — Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

Same operation — other Qualifier

Same table and root operation, differing only in the qualifier character.

3E0J7U0 — Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

Same procedure category (CCSR), other tables

AHRQ's Clinical Classifications Software Refined groups these ICD-10-PCS procedures with this one under Administration and transfusion of bone marrow, stem cells, pancreatic islet cells, and t-cells (Administration of Therapeutic Substances); listed here are the members in other PCS tables. Source: Clinical Classifications Software Refined (CCSR), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, November 2025.

30243U3 — Transfusion of Allogeneic Unrelated T-cell Depleted Hematopoietic Stem Cells into Central Vein, Percutaneous Approach, 30243U4 — Transfusion of Allogeneic Unspecified T-cell Depleted Hematopoietic Stem Cells into Central Vein, Percutaneous Approach, 30243X0 — Transfusion of Autologous Cord Blood Stem Cells into Central Vein, Percutaneous Approach, 30243X2 — Transfusion of Allogeneic Related Cord Blood Stem Cells into Central Vein, Percutaneous Approach, 30243X3 — Transfusion of Allogeneic Unrelated Cord Blood Stem Cells into Central Vein, Percutaneous Approach, 30243X4 — Transfusion of Allogeneic Unspecified Cord Blood Stem Cells into Central Vein, Percutaneous Approach, 30243Y0 — Transfusion of Autologous Hematopoietic Stem Cells into Central Vein, Percutaneous Approach, 30243Y2 — Transfusion of Allogeneic Related Hematopoietic Stem Cells into Central Vein, Percutaneous Approach, 30243Y3 — Transfusion of Allogeneic Unrelated Hematopoietic Stem Cells into Central Vein, Percutaneous Approach, 30243Y4 — Transfusion of Allogeneic Unspecified Hematopoietic Stem Cells into Central Vein, Percutaneous Approach, XW020D8 — Introduction of Engineered Allogeneic Thymus Tissue into Muscle, Open Approach, New Technology Group 8, XW033DA — Introduction of Donislecel-jujn Allogeneic Pancreatic Islet Cellular Suspension into Peripheral Vein, Percutaneous Approach, New Technology Group 10, XW1337A — Transfusion of Marnetegragene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 10, XW133B8 — Transfusion of Betibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8, XW133C8 — Transfusion of Omidubicel into Peripheral Vein, Percutaneous Approach, New Technology Group 8, XW133F8 — Transfusion of OTL-103 into Peripheral Vein, Percutaneous Approach, New Technology Group 8, XW133G8 — Transfusion of Atidarsagene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8, XW133H9 — Transfusion of Lovotibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 9, XW133J8 — Transfusion of Exagamglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8, XW133SB — Transfusion of Mozafancogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 11, +30 more

Contextual Map

Every relationship of 3E0J7U1 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.

Run 3E0J7U1 with these 5 related codes in Claim Check

PCS table

MS-DRG participation

Clinical classification (CCSR)

MDC crossing · diagnoses (721)

  • MDC 11 — Diseases and Disorders of the Kidney and Urinary Tract[MDC crossing]: “Diseases and Disorders of the Kidney and Urinary Tract — the grouper's crossing between diagnoses and procedures: a principal diagnosis sets the MDC, and same-MDC procedures move the stay to its surgical DRGs.”— CMS MS-DRG Definitions Manual · FY2026
  • A18.10 — Tuberculosis of genitourinary system, unspecified[Same-MDC diagnosis]: “Tuberculosis of genitourinary system, unspecified — grouped in MDC 11, the diagnosis side of this code's crossing.”— CMS MS-DRG Definitions Manual (Appendix B) · FY2026
  • A18.11 — Tuberculosis of kidney and ureter[Same-MDC diagnosis]: “Tuberculosis of kidney and ureter — grouped in MDC 11, the diagnosis side of this code's crossing.”— CMS MS-DRG Definitions Manual (Appendix B) · FY2026
  • A18.12 — Tuberculosis of bladder[Same-MDC diagnosis]: “Tuberculosis of bladder — grouped in MDC 11, the diagnosis side of this code's crossing.”— CMS MS-DRG Definitions Manual (Appendix B) · FY2026
  • A18.13 — Tuberculosis of other urinary organs[Same-MDC diagnosis]: “Tuberculosis of other urinary organs — grouped in MDC 11, the diagnosis side of this code's crossing.”— CMS MS-DRG Definitions Manual (Appendix B) · FY2026
  • A36.85 — Diphtheritic cystitis[Same-MDC diagnosis]: “Diphtheritic cystitis — grouped in MDC 11, the diagnosis side of this code's crossing.”— CMS MS-DRG Definitions Manual (Appendix B) · FY2026
  • and 716 more

Nearest codes

Change history

No changes recorded for this code. This ledger tracks additions, deletions and description changes from FY2026 (April) onward. Note changes are not tracked.

Read from: CMS ICD-10-PCS code tables, index and definitions — FY2026 (April); CMS MS-DRG Definitions Manual (incl. Appendix B diagnosis index, Appendix C CC/MCC list, Appendix E procedure index) and IPPS Final Rule tables — v43; AHRQ HCUP Clinical Classifications Software Refined for ICD-10-PCS Procedures (hcup-us.ahrq.gov/toolssoftware/ccsr/PRCCSR_v2026-1.zip) — v2026.1. All data sources · How to read the labels